MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

09 Nov 2022 Evaluate
A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 5.71 millions during year ago period.The Net Loss for the quarter ended September 2022 is Rs. -5.46 millions as compared to Net Profit of Rs. 0.71 millions of corresponding quarter ended September 2021Operating profit Margin for the quarter ended September 2022 slipped to -5.36% as compared to 0.76% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 5.71 0.00 0.00 29.12 0.00 39.39 85.51 -53.94
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.26 -42.31
PBIDT -5.36 0.76 -805.26 -5.91 1.22 -584.43 1.52 1.33 14.29
Interest 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.00 0.00
PBDT -5.36 0.76 -805.26 -5.94 1.22 -586.89 1.49 1.33 12.03
Depreciation 0.06 0.04 50.00 0.06 0.08 -25.00 0.09 0.45 -80.00
PBT -5.42 0.72 -852.78 -6.00 1.14 -626.32 1.40 0.88 59.09
TAX 0.04 0.01 300.00 0.89 0.33 169.70 -0.05 -0.05 0.00
Deferred Tax 0.04 0.01 300.00 0.89 0.33 169.70 -0.05 -0.05 0.00
PAT -5.46 0.71 -869.01 -6.89 0.81 -950.62 1.45 0.93 55.91
Equity 102.69 102.69 0.00 103.11 103.11 0.00 102.69 102.69 0.00
PBIDTM(%) 0.00 13.31 0.00 0.00 4.19 0.00 3.86 1.56 148.09
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..